The Runx2/Cbfa1 transcription factor regulates a program of gene expression necessary for skeletal development. To understand signals mediating skeletal formation, we examined the in vivo spatio-temporal activity of the Runx2 P1 promoter which controls expression of the bone-related Type II isoform. Transgenic mice carrying 3 kb of Runx2 promoter fused to the lacZ gene exhibit localized promoter activity in early mesenchymal condensations shortly after the embryonic turning event. Expression in developing mesenchyme continues throughout chondrogenesis and is restricted to the axial skeleton. Our data support a function for Runx2 in establishment of the prechondrocytic skeletal primordium. q
Results and discussion
Skeletal formation is a multistep process initiated by mesenchymal cells that form the skeleton through intramembranous and endochondral ossification. The Runx2 runt-homology domain transcription factor is expressed at early stages of embryonic development and is essential for bone formation Komori et al., 1997; Otto et al., 1997) . Runx2 regulates osteoblast (Banerjee et al., 1997; Ducy et al., 1997) and chondrocyte maturation (Akiyama et al., 1999; Enomoto et al., 2000; Kim et al., 1999) . Thus, this gene must be responsive to both chondrogenic and osteogenic signaling pathways.
The Runx2 P1 promoter controls expression of the Type II isoform that is highly expressed in differentiating osteoblasts and responsive to the osteogenic BMP-2 signal (Banerjee et al., 2001; Drissi et al., 2000, in press ). This study addresses the in vivo contributions of a 3 kb segment of the Runx2 P1 promoter to the highly specific spatiotemporal events that mediate bone formation.
Activity of a Runx2 P1-lac Z transgene was assessed by b-galactosidase detection throughout mouse embryonic development (Fig. 1A) . Transgene expression is evident in two lines shortly after embryonic turning at 8.5 days post coitum (dpc) (not shown) in the most caudal somites that give rise to sclerotome around 9.5 dpc (Fig. 1B) . Promoter activity continues in the developing sclerotome until 11.5 dpc (Fig. 1C) . At 12.5 dpc, b-galactosidase expression is located solely in the mesenchyme of sclerotomes which are destined to form the axial skeleton (Fig. 1D) . Therefore, the 3 kb Runx2 promoter contains regulatory elements that control Runx2 expression in early mesenchymal cells that will form the vertebrae and ribs.
When cells of the sclerotome begin to migrate in a ventromedial fashion at 13.5 dpc to form the cartilage anlagen of the ribs, we find intense b-galactosidase activity at the tip of the migrating rib ( Fig. 2A,B) . Parasagittal rib sections show that cells expressing b-galactosidase have not yet produced significant cartilaginous extracellular matrix (Fig. 2E,F) . Runx2 promoter activity continues during mesenchymal cell differentiation in the region that will become the cartilage of the developing rib. Thus, the promoter is highly active in committed chondroprogenitor cells.
At 13.5 dpc, cells of the sclerotome also begin to segregate along the vertebral column to form the future vertebral bodies (Fig. 2C,D ,G,H) and intervertebral discs (Fig. 2G,H) . Cells positive for transgene expression are destined to become intervertebral discs (Fig. 2H) , indicating that the Runx2 promoter is active in prechondrogenic cells of the intervertebral discs and ribs and that promoter activity is absent from chondrocytes which form the template for future bone tissue of the vertebral body. Parasagittal sectioning of 15.5 dpc embryos also reveals strong transgene activity in the ribs but a complete lack of activity in the alkaline phosphatase positive humerus and developing parietal bone of the skull (Fig. 3A-C) . We conclude that Runx2 promoter activity demarcates a segmentation event involved in formation of the axial skeleton.
In the rib and vertebral bodies of 15.5 dpc embryos, mature chondrocytes (Fig. 3D,G) exhibit strong b-galactosidase activity (Fig. 3E,H) , which decreases towards the hypertrophic zone (Fig. 3D-I ). Regions exhibiting alkaline phosphatase staining and b-galactosidase activity are mutually exclusive (Fig. 3E,F,H,I ). Cells of the rib perios- (Drissi et al., 2000) . SacI sites used for genomic DNA digestion and 1100 bp probe used for genotyping transgenic animals are indicated. (B-D) Whole-mount X-gal staining was performed as described elsewhere (Kim et al., 1999) on transgenic embryos from 9.5 (B), 11.5 (C), and 12.5 dpc (D) with fixation times increasing with age. Three-kilobase Runx2 promoter activity progresses from the caudal somites (B) into developing sclerotomal mesenchyme (C,D) prior to the onset of chondrogenesis. Fig. 2 . The bone-related Runx2 3 kb promoter is expressed in mesenchymal condensations and the developing axial skeleton. Whole-mount X-gal staining of 13.5 dpc animals followed by soft tissue clarification in 2% KOH shows strong transgene activity in the ventromedially migrating cells of the developing rib (A,B, arrow). A closer view of the rib cage (B, arrowhead) shows a decrease in transgene activity towards the developing vertebral column. Cryosectioning of entire 13.5 dpc transgenic embryos followed by X-gal (D,F,H) or Safranine-O (C,E,G) staining reveals transgene activity in the caudal sclerotomes (C,D). Parasagittal section of the developing ribs at higher magnification reveals transgene activity in prechondrocytic cells (F, arrow; eosin counterstain). These cells are not yet producing a mature cartilaginous extracellular matrix as evidenced by the absence of Safranine-O staining (E, arrow). A midsagittal section of the developing vertebral column reveals Runx2 P1 promoter activity in mesenchymal cells which will give rise to the intervertebral discs (H, arrowhead) in a region where the cartilaginous ECM is not yet mature, as evidenced by absence of Safranine-O staining (G, arrowhead) . Condensations of cells that will form the vertebral bodies exhibit weak Safranine-O staining at this time (G,H, arrows). teum, which have both chondrogenic and osteogenic potential, also express the transgene (Fig. 3E ). This expression profile was observed until birth (Fig. 4A,B) , indicating that the 3 kb Runx2 promoter is silenced in hypertrophic chondrocytes. We examined transgene expression in skeletal tissues and major organs from mature mice. Runx2 promoter activity was detected only in the seminiferous tubules of the testes (Fig. 4C,D) , consistent with expression of the Type II Runx2 isoform (Ogawa et al., 2000) . Our findings suggest that sequences beyond 3 kb are required for Runx2 promoter activity in mineralized tissue and chondrocytes of adult animals.
This study represents the first data on developmental expression of the Runx2 P1 promoter in vivo. We show robust expression of the Runx2 P1 promoter in relation to chondrogenesis and observe promoter activity in prechondrocytic mesenchymal condensations and in mature chondrocytes of the developing axial skeleton, but not in the appendicular limbs. Although additional sequences may contribute to endogenous Runx2 P1 promoter activity, the 3 kb Runx2 P1 promoter is responsive to developmental cues that establish the segmentation pattern of the ribs and vertebrae. Several groups have identified Runx2 transcripts in pre-chondrocytic mesenchyme, hypertrophic, and prehypertrophic chondrocytes of vertebrae and limb bones (Ducy et al., 1997; Enomoto et al., 2000; Inada et al., 1999; Kim et al., 1999) as well as in dental mesenchyme and odontoprogenitor cells (D'Souza et al., 1999) . Our results show that the 3 kb Runx2 promoter contains regulatory information for activation in a subset of chondrocyte lineage cells expressing the endogenous gene and therefore is responsive to signals transduced by spatio-temporal regulatory pathways in such cells. We propose that the Runx2 P1 promoter provides a basis for exploring the complexities of Runx2 in regulating initial stages of chondrogenesis and segmentation of the axial skeleton.
